Taken together, these findings begin to show underlying mechanisms through which LMP1 modified EVs can remodel the tumor microenvironment by degrading the ECM and hence increasing the metastatic capabilities of the EBV associated cancers. This evidence concerns the gene PDLIM7 and neoplasm.